Kynurenine pathway metabolites: Relevant to vitamin B-6 deficiency and beyond

American Journal of Clinical Nutrition

Volumn 98, Issue 4, 2013, Pages 863-864

  Ciorba, Matthew A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYLANTHRANILIC ACID; AROMATIC HYDROCARBON RECEPTOR; C REACTIVE PROTEIN; CYANOCOBALAMIN; DRUG METABOLITE; FOLIC ACID; KYNURENIC ACID; KYNURENINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; QUINOLINIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG; XANTHURANIC ACID;

DIET SUPPLEMENTATION; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HYPERHOMOCYSTEINEMIA; PYRIDOXINE DEFICIENCY;

3-HYDROXYANTHRANILIC ACID; FEMALE; HUMANS; KYNURENINE; MALE; PYRIDOXAL PHOSPHATE; VITAMIN B 6 DEFICIENCY; XANTHURENATES;

EID: 84884894366     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.072025     Document Type: Editorial

References (12)

1. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53. (Pubitemid 23019020)
2. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen E, Nygard O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008; 300:795-804.
3. Ulvik A, Theofylaktopoulou D, Midttun Ø, Nygard O, Eussen SJPM, Ueland PM. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. Am J Clin Nutr 2013;98:934-40.
4. Midttun O, Ulvik A, Ringdal Pedersen E, Ebbing M, Bleie O, Schartum- Hansen H, Milsen RM, Nygard O, Ueland PM. Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J Nutr 2011;141:611-7.
5. Fallarino F, Grohmann U, Vacca C, Orabona C, Spreca A, Fioretti MC, Puccetti P. T cell apoptosis by kynurenines. Adv Exp Med Biol 2003; 527:183-90. (Pubitemid 38197643)
6. Thaker AI, Rao MS, Bishnupuri KS, Kerr TA, Foster L, Marinshaw JM, Newberry RD, Stenson WF, Ciorba MA. IDO1 metabolites activate beta-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. Gastroenterology 2013;145(2):416-25.e4.
7. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011;478:197-203.
8. Pedersen ER, Svingen GF, Schartum-Hansen H, Ueland PM, Ebbing M, Nordrehaug JE, Igland J, Seifert R, Nilsen RM, Nygard O. Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography. Eur Heart J (Epub ahead of print 25 July 2013).
9. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 2012;13:465-77.
10. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm Bowel Dis 2012;18: 1214-20.
11. Ciorba MA. Indoleamine 2,3 dioxygenase in intestinal disease. Curr Opin Gastroenterol 2013;29:146-52.
12. Rios-Avila L, Nijhout HF, Reed MC, Sitren HS, Gregory JF III. A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2,3-dioxygenase on tryptophan metabolites. J Nutr 2013;143:1509-19. Diseases Diseases